DOSAGE ADJUSTMENT OF TOMOXETIN IN EMS MAY BE NECESSARY WHEN COADMINISTERED WITH CYP2D6 INHIBITORS, E.G., PAROXETINE, FLUOXETINE, AND QUINIDINE. ALBUTEROL (600 MCG IV OVER 2 HOURS) INDUCED INCREASES IN HEART RATE AND BLOOD PRESSURE. THESE EFFECTS WERE POTENTIATED BY ATOMOXETINE (60 MG BID FOR 5 DAYS) AND WERE MOST MARKED AFTER THE INITIAL COADMINISTRATION OF ALBUTEROL AND ATOMOXETINE.
SHOULD NOT BE GIVEN WITH MAO INHIBITORS OR WITHIN 2 WEEKS OF INITIATING OR DISCONTINUING THE THERAPY WITH MAOS, CAN CAUSE NEUROLEPTIC MALIGNANT SYNDROME LIKE ADVERSE REACTION.